January 17, 2007, Santa Ana, CA--Advanced Medical Optics, a global ophthalmic surgical and eye care products company, today announced the acquisition of WaveFront Sciences a provider of proprietary wavefront diagnostic systems for refractive surgery and medical research.
WaveFront Sciences designs and manufactures a Shack-Hartmann based aberrometer that precisely measures the total refractive error and wavefront aberrations of the human eye as part of the wavefront-guided custom laser vision correction procedure. The acquisition expands AMO's portfolio of laser technologies and strengthens its pipeline of new wavefront-guided diagnostic innovations.
"WaveFront Sciences has earned an excellent reputation in the ophthalmic industry for its cutting-edge diagnostics," said AMO Chairman, President and CEO Jim Mazzo. "This acquisition represents another step forward in AMO's strategy to provide a full range of products and services that meets the needs of comprehensive refractive practices. With this transaction, we secure proprietary technologies and R&D expertise in wavefront sensing and laser optics, which we expect will allow us to further strengthen our Advanced CustomVue laser vision correction technology and accelerate the introduction of next generation diagnostics that build on our WaveScan Wavefront systems."
"WaveFront Sciences looks forward to supporting and contributing to AMO's growth and business objectives while enabling practitioners to provide state-of-the-art surgical planning and diagnostics for their patients," said WaveFront Sciences CEO Tim Turner.
For more information, contact Advanced Medical Optics.